(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B | 4.66%530.89B | 1.38%242.96B | 9.95%1.05T | 11.12%750.79B | 11.00%507.26B | 17.95%239.66B | 27.59%951.59B |
Operating income | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B | 4.66%530.89B | 1.38%242.96B | 9.95%1.05T | 11.12%750.79B | 11.00%507.26B | 17.95%239.66B | 27.59%951.59B |
Cost of sales | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B | -3.54%-453.44B | -0.35%-206.94B | -9.32%-899.16B | -10.54%-645.25B | -10.55%-437.92B | -18.47%-206.21B | -29.19%-822.53B |
Operating expenses | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B | -3.54%-453.44B | -0.35%-206.94B | -9.32%-899.16B | -10.54%-645.25B | -10.55%-437.92B | -18.47%-206.21B | -29.19%-822.53B |
Gross profit | 10.42%39.77B | 8.59%159.7B | 10.11%116.2B | 11.70%77.45B | 7.69%36.02B | 13.95%147.07B | 14.78%105.54B | 13.95%69.34B | 14.85%33.45B | 18.29%129.07B |
Selling expenses | -15.60%-9.25B | -6.25%-40.13B | -4.79%-27.02B | -4.87%-19.07B | 8.04%-8.01B | 2.51%-37.77B | -1.60%-25.79B | -3.24%-18.18B | -24.37%-8.71B | -42.67%-38.74B |
Administrative expenses | 20.99%-1.98B | 12.15%-9.71B | 1.01%-7.33B | -1.48%-4.86B | -1.58%-2.5B | 4.40%-11.05B | 5.33%-7.41B | -0.29%-4.79B | -11.25%-2.46B | -80.40%-11.56B |
Research and development expenses | 3.63%-4.03B | 2.96%-16.39B | 3.79%-12.05B | 1.82%-8.26B | 4.52%-4.19B | -3.43%-16.89B | -2.45%-12.53B | -2.29%-8.41B | 3.22%-4.38B | -1.13%-16.33B |
Profit from asset sales | ---- | 65.55%2.28B | 20.50%1.48B | --1.48B | --472M | 79.79%1.38B | 64.09%1.23B | ---- | ---- | -53.49%767M |
Impairment and provision | ---- | ---5.17B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---3.14B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | ---2.03B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -9.34%-16.81B | -2.46%-64.56B | -2.44%-47.28B | -0.81%-32.05B | 0.74%-15.37B | -6.70%-63.01B | -8.00%-46.15B | -11.74%-31.79B | -12.19%-15.49B | -21.26%-59.06B |
Operating profit | 19.81%7.7B | 31.95%26.03B | 61.13%24B | 138.36%14.7B | 166.79%6.43B | 376.29%19.72B | 228.59%14.9B | 214.43%6.17B | 45.12%2.41B | -66.45%4.14B |
Financing cost | -1.86%-601M | -36.80%-2.88B | -38.78%-1.95B | -50.24%-1.24B | -71.01%-590M | -73.62%-2.11B | -83.81%-1.41B | -68.64%-828M | -33.72%-345M | -7.82%-1.21B |
Special items of earning before tax | -0.25%1.97B | 326.83%8.51B | 283.29%6.3B | 236.44%4.09B | 139.59%1.97B | 31.92%-3.75B | -183.03%-3.44B | -181.02%-3B | -283.05%-4.98B | -113.91%-5.51B |
Earning before tax | 16.10%9.07B | 128.24%31.65B | 182.00%28.34B | 649.34%17.54B | 367.86%7.81B | 637.48%13.87B | 293.69%10.05B | -54.71%2.34B | -170.72%-2.92B | -105.08%-2.58B |
Tax | -5.66%-1.7B | -100.98%-8.39B | -95.45%-7B | -141.40%-4.42B | -166.83%-1.61B | -121.30%-4.18B | -110.40%-3.58B | -74.55%-1.83B | -25.63%-603M | -27.33%-1.89B |
After-tax profit from continuing operations | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B | 2,472.94%13.12B | 276.21%6.2B | 316.95%9.69B | 660.28%6.47B | -87.62%510M | -196.60%-3.52B | -109.05%-4.47B |
Earning after tax | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B | 2,472.94%13.12B | 276.21%6.2B | 316.95%9.69B | 660.28%6.47B | -87.62%510M | -196.60%-3.52B | -109.05%-4.47B |
Minority profit | 479.03%235M | -32.08%-910M | 164.58%567M | 132.00%280M | 88.24%-62M | 24.04%-689M | -16.45%-878M | -199.66%-875M | -2,208.00%-527M | -1,233.82%-907M |
Profit attributable to shareholders | 13.88%7.13B | 132.82%24.17B | 182.77%20.78B | 827.22%12.84B | 309.33%6.26B | 391.57%10.38B | 357.82%7.35B | -68.61%1.39B | -182.69%-2.99B | -107.21%-3.56B |
Basic earnings per share | 14.57%2.28 | 131.63%7.69 | 181.28%6.61 | 808.89%4.09 | 307.29%1.99 | 388.70%3.32 | 351.92%2.35 | -68.31%0.45 | -182.76%-0.96 | -107.03%-1.15 |
Diluted earnings per share | 15.82%2.27 | 137.07%7.61 | 194.59%6.54 | 839.53%4.04 | 304.17%1.96 | 379.13%3.21 | 344.00%2.22 | -68.84%0.43 | -184.96%-0.96 | -107.26%-1.15 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu, PricewaterhouseCoopers | -- | -- | -- | Deloitte & Touche Tohmatsu, PricewaterhouseCoopers | -- | -- | -- | Deloitte & Touche Tohmatsu, PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data